Skip to main content
. Author manuscript; available in PMC: 2023 Nov 1.
Published in final edited form as: J Cyst Fibros. 2022 May 4;21(6):1020–1026. doi: 10.1016/j.jcf.2022.04.014

Table 4. Symptom reporting per participant during the study.

Reports of symptoms include physician documentation at clinic visits as well as parental reports via weekly phone calls. Resolution of symptoms was not recorded; the same episode of symptoms may have been reported more than once.

Number of
Reports of
Symptoms


Median
(IQR)
Number of
Reports of
Symptoms
Virus Positive

Median
(IQR)
Number of
Reports of
Symptoms
Virus Negative

Median
(IQR)
Number of
Reports of
Symptoms with
no Nasal Swabs
obtained
Median
(IQR)
Any symptoms (Parental report + physician document) 11 (7, 15) 2 (0, 4) 3 (1, 5) 3 (0, 5)
Any nasal symptoms 7 (3, 10) 2 (0, 3) 2 (0, 3) 2 (0, 4)
Any cough 6 (3, 9) 1 (0, 3) 2 (0, 3) 2 (0, 4)
Wheeze 1 (0, 2) 0 (0, 1) 0 (0, 1) 0 (0, 1)
Altered breathing 0 (0, 2) 0 (0, 1) 0 (0, 0) 0 (0, 0)
Fever 0 (0, 1) 0 (0, 0) 0 (0, 0) 0 (0, 0)
Reduced activity 1 (0, 2) 0 (0, 1) 0 (0, 0) 0 (0, 0)
Nasal symptoms only (no cough, wheeze, or altered breathing) 4 (2, 6) 0 (0, 1) 1 (0, 2) 2 (0, 4)
Upper respiratory tract symptoms (cough, no wheeze or altered breathing) 5 (3, 7) 1 (0, 2) 2 (0, 4) 4 (2, 6)
Lower respiratory tract symptoms (wheezing and/or altered breathing) 1 (0, 4) 0 (0, 1) 0 (0, 1) 0 (0, 1)